ACMSD Antikörper (AA 33-129) (FITC)
Kurzübersicht für ACMSD Antikörper (AA 33-129) (FITC) (ABIN7142144)
Target
Alle ACMSD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 33-129
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase protein (33-129AA)
-
Isotyp
- IgG
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))
-
Andere Bezeichnung
- ACMSD
-
Hintergrund
-
Background: Converts alpha-amino-beta-carboxymuconate-epsilon-semialdehyde (ACMS) to alpha-aminomuconate semialdehyde (AMS). ACMS can be converted non-enzymatically to quinolate (QA), a key precursor of NAD, and a potent endogenous excitotoxin of neuronal cells which is implicated in the pathogenesis of various neurodegenerative disorders. In the presence of ACMSD, ACMS is converted to AMS, a benign catabolite. ACMSD ultimately controls the metabolic fate of tryptophan catabolism along the kynurenine pathway.
Aliases: 2 amino 3 carboxymuconate 6 semialdehyde decarboxylase antibody, 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase antibody, acmsd antibody, ACMSD_HUMAN antibody, Aminocarboxymuconate semialdehyde decarboxylase antibody, Picolinate carboxylase antibody
-
UniProt
- Q8TDX5
Target
-